Jain Global’s Immunic IMUX Stock Holding History

Jain Global’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,662	Closed	-$39.9K	–	1391
2025 Q1	$39.9K	Buy	+3,662	New	+$39.5K	﹤0.01%	1020

Other funds holding IMUX

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Jain Global's IMUX Position: Q2 2025 in Review

Jain Global sold out of Immunic (IMUX) in Q2 2025, closing a stake of 3,662 shares — an estimated $39.9K sold.

Jain Global first reported a position in IMUX in Q1 2025 and held it in 1 quarter. The position peaked at $39.9K in Q1 2025. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2025.

Jain Global reported no remaining Immunic position as of Q2 2025 after selling out during the quarter.
Jain Global sold 3,662 Immunic shares in Q2 2025, an estimated $39.9K.
Jain Global first reported a position in Immunic in Q1 2025 and held it in 1 quarter.
Jain Global's Immunic position peaked at $39.9K in Q1 2025.
55 funds tracked by Wall St. Rank held Immunic as of Q2 2025.

Based on Jain Global's 13F filing for Q2 2025, filed 14 Aug 2025.